These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2077154)
1. [Combination effects of fosfomycin and other oral antimicrobial agents against methicillin-resistant Staphylococcus aureus]. Akiyama H; Yamada T; Shimoe K; Torigoe R; Kanzaki H; Arata J Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(12):1257-61. PubMed ID: 2077154 [TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field. Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448 [TBL] [Abstract][Full Text] [Related]
3. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems]. Kouda M Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774 [TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activity of norfloxacin on methicillin-resistant Staphylococcus aureus. Comparison with oral antibacterial agents]. Iwata S; Kawashima C; Sakamoto H; Isohata E; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Oikawa T Jpn J Antibiot; 1990 Feb; 43(2):228-32. PubMed ID: 2362350 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa]. Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267 [TBL] [Abstract][Full Text] [Related]
6. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus]. Saionji K; Shitara S; Kobayashi I Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289 [TBL] [Abstract][Full Text] [Related]
7. [In vitro study of the effects of an imipenem-fosfomycin combination against clinical strains of Staphylococcus]. Fosse T; David MF; Duluc F Pathol Biol (Paris); 1986 Dec; 34(10):1055-9. PubMed ID: 3547260 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin. Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650 [TBL] [Abstract][Full Text] [Related]
9. [Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1994 Jun; 47(6):693-700. PubMed ID: 8072177 [TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus]. Saionji K; Shitara M; Miyake N; Inoue K; Kobayashi I Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811 [TBL] [Abstract][Full Text] [Related]
11. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793 [TBL] [Abstract][Full Text] [Related]
13. [Activities of antibiotics against methicillin-resistant Staphylococcus aureus with particular reference to synergetic effect between ticarcillin and fosfomycin on penicillinase non-producing methicillin-resistant S. aureus]. Morikawa Y; Yoshioka Y; Toshima M Jpn J Antibiot; 1993 Jun; 46(6):421-7. PubMed ID: 8360977 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus. Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368 [TBL] [Abstract][Full Text] [Related]
15. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Lawrence KR; Golik MV; Davidson L Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720 [TBL] [Abstract][Full Text] [Related]
16. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus]. David C; Chaste A; Saison C; Combremont AG Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735 [TBL] [Abstract][Full Text] [Related]
17. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Kono K; Takeda S; Tatara I; Arakawa K Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibility and beta-lactamase-producing strains of methicillin-resistant Staphylococcus aureus]. Akimoto Y; Kaneko K; Fujii A Nichidai Koko Kagaku; 1989 Sep; 15(3):338-41. PubMed ID: 2489806 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics. Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]